Here, we found that the PKCδ phosphorylation was significantly increased in lung tissue of patients with pulmonary fibrosis and the PKCδ deficiency enhanced BLM-induced inflammation and pulmonary fibrosis, suggesting that PKCδ plays a protective role in IPF. Here, PRKCD is linked to pulmonary fibrosis.